Krystal, J. H., Abdallah, C. G., Averill, L. A., Kelmendi, B., Harpaz-Rotem, I., Sanacora, G., . . . Duman, R. S. (2017). Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic. Curr Psychiatry Rep.

Krystal, John H., Chadi G. Abdallah, Lynette A. Averill, Benjamin Kelmendi, Ilan Harpaz-Rotem, Gerard Sanacora, Steven M. Southwick, and Ronald S. Duman. "Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine As a Prototype Novel Therapeutic." Curr Psychiatry Rep 2017.

Krystal, John H., et al. "Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine As a Prototype Novel Therapeutic." Curr Psychiatry Rep 2017.